LAVA Therapeutics N.V. (LVTX) Misses Q2 EPS by 2c

LAVA Therapeutics N.V. (NASDAQ: LVTX) reported Q2 EPS of ($0.32), $0.02 worse than the analyst estimate of ($0.30).

For earnings history and earnings-related data on LAVA Therapeutics N.V. (LVTX) click here.

You May Also Be Interested In

• GameStop CEO Cohen buys 1.15M shares
• Sun Life to consolidate preferred shares Series 11QR into Series 10R
• Boeing wins defense contracts worth $41.5m for aircraft support